Tovorafenib

Name: Pharmaffiliates
Address: Plot Number 225 ,Industrial Area, Phase II, Panchkula, 134109, IN
Telephone: +91-172-5066494
Price range: $650-$950

Tovorafenib, known as Ojemda, is an oral, selective type II RAF kinase inhibitor for treating children aged 6 months and older with relapsed or refractory pediatric low-grade glioma (pLGG) having a BRAF fusion, rearrangement, or V600E mutation. Reference standards of Tovorafenib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Tovorafenib
    [catalogue_number] => PA 20 4120000
    [category_ids] => ,70,78,82,76,
    [chemical_name] => 
    [weight] => 506.29
    [form] => C17H12Cl2F3N7O2S
    [cas] => 1096708-71-2
    [pslug] => 1096708-71-2-tovorafenib-pa204120000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)